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Abstract
Background: Pain is a common symptom, often associated with neurological and musculoskeletal conditions, and
experienced especially by females and by older people, and with increasing trends in general populations. Different
risk factors for pain have been identified, but generally from studies with limited samples and a limited number of
candidate predictors. The aim of this study is to evaluate the predictors of pain from a large set of variables and
respondents.
Methods: We used part of the harmonized dataset of ATHLOS project, selecting studies and waves with a longitudinal
course, and in which pain was absent at baseline and with no missing at follow-up. Predictors were selected based on
missing distribution and univariable association with pain, and were selected from the following domains: Socio-
demographic and economic characteristics, Lifestyle and health behaviours, Health status and functional limitations,
Diseases, Physical measures, Cognition, personality and other psychological measures, and Social environment.
Hierarchical logistic regression models were then applied to identify significant predictors.
Results: A total of 13,545 subjects were included of whom 5348 (39.5%) developed pain between baseline and the
average 5.2 years’ follow-up. Baseline risk factors for pain were female gender (OR 1.34), engaging in vigorous exercise
(OR 2.51), being obese (OR 1.36) and suffering from the loss of a close person (OR 1.88) whereas follow-up risk factors
were low energy levels/fatigue (1.93), difficulties with walking (1.69), self-rated health referred as poor (OR 2.20) or
average to moderate (OR 1.57) and presence of sleep problems (1.80).
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Conclusions: Our results showed that 39.5% of respondents developed pain over a five-year follow-up period, that
there are proximal and distal risk factors for pain, and that part of them are directly modifiable. Actions aimed at
improving sleep, reducing weight among obese people and treating fatigue would positively impact on pain onset,
and avoiding vigorous exercise should be advised to people aged 60 or over, in particular if female or obese.
Keywords: Pain, Risk factors, Headache disorders, Musculoskeletal disorders, Sleep, Obesity, Exercise, Bereavement,
Fatigue, Walking
Introduction
Pain is one of the most common symptoms in general
populations and is the core symptom of many common,
and often comorbid, clinical conditions. In fact, the preva-
lence of pain-associated conditions is between 10% and
60% approximately, with the highest rates being observed
for tension-type headache [1–11]. Data referred to general
populations are on the contrary almost lacking. A recent
study from the U.S. showed that the overall rates of non-
cancer pain prevalence increased from 32.9% to 41.0%
over an 18-years period (1997–98 to 2013–14) [12]. Such
an information was confirmed in a recent study based on
the harmonized dataset generated by ATHLOS project
(Ageing Trajectories of Health – Longitudinal Opportun-
ities and Synergies) [13]. Such a recent paper showed that
pain rates largely vary by sex, participants’ age, period of
inclusion in the studies and birth cohort [14]. In particu-
lar, pain rates were shown to vary between 20 and 30% in
males enrolled in the early 1990s, and 60–70% among
old-age women enrolled between 2011 and 2015. In
addition to this, the 10-years forecast suggested an in-
crease in the trends of pain which will peak up to 20%
among females and among older subjects [14].
Given the observed and predicted increase of pain
rates, determinants need to be addressed in order to
limit to the widest extent the possible negative conse-
quences of such an expansion, for example the risk of
future opioids and other drugs’ overuse, increase in dis-
ability, reduction in quality of life and employment rates,
and productivity loss [15–25]. A large amount of studies
identified potential predictors of pain, both in clinical
trials and in population or cohort studies. Among popu-
lation and cohort studies, evidence existed on the impact
of sociodemographic characteristics, with females [26–
33] and older people [6, 27, 28, 31, 32, 34] reporting
higher pain rates or severity. Also, people with lower
education level and those unemployed had higher pain
rates [35, 36], but contrasting results were found with
reference to socioeconomic position: in fact, Chen and
colleagues found that people with a lower socioeconomic
class had a more severe trajectory with regard to low
back pain severity and persistence [37], whereas Elshary-
dah and colleagues found that higher median household
income was associated with higher rate of complex
regional pain syndrome type 1 [30]. Evidence was also
found on the impact of some mental health problems
and symptoms on pain rates and severity, including sleep
problems [6, 27, 34, 38, 39], depressed mood or anxiety
[26, 28–30, 34, 35, 39, 40], cognitive complaints [34] and
fatigue or lack of energy [38]. Other health status vari-
ables that were found to be associated with higher pain
rates and severity included the presence of comorbidities
and multimorbidity status [6, 26, 30, 35, 39, 41] and,
among single heath conditions, diabetes and stroke [30,
42, 43]: of course, presence of conditions whose cardinal
symptom is pain, such as headaches, musculoskeletal
conditions or angina, is clearly acknowledged to impact
on pain. Finally, a set of risk and protective lifestyle fac-
tors were also identified. Physical activity was found to
be protective against back pain onset among older adult
women [29], smoking was found to be a risk factor for
the development of chronic musculoskeletal pain [44],
and high body mass index (BMI) or obesity status were
risk factors for higher pain rates, development of muscu-
loskeletal conditions and pain worsening [6, 27, 29, 30,
33, 35, 45, 46].
The information herein available is however limited to
specific cohorts, such as military or farmers, or cohort of
patients, with population studies presenting a limited
amount of pain predictors, a relatively limited amount of
participants, with different ages and a limited geograph-
ical distribution. This provides a partial appreciation of
global pain predictors, which can be on the contrary
achieved through an analysis of a large dataset such as
that of ATHLOS project, where data from 17 different
population survey conducted in the five continents were
harmonized [13]. This paper aims to provide the most
comprehensive identification of pain predictors in ageing
populations.
Methods
Study population
The last available wave of each study (i.e. harmonized in
the ATHLOS project) was defined as follow-up wave,
while the baseline wave was selected trying to keep,
when possible, one wave in between the two. The base-
line wave did not necessarily coincide with study’s base-
line wave.
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The studies and waves selected for the present ana-
lyses were: the China Health and Retirement Longitu-
dinal Study (CHARLS: W1-W2), the Collaborative
Research on Ageing in Europe (COURAGE in Europe:
W1-W2), the Health and Retirement Study (HRS: W9-
W11), the Health 2000/2011 study (W1-W2), the Mexi-
can Health and Aging Study (MHAS: W2-W3), and the
Survey of Health, Ageing and Retirement in Europe
(SHARE: W4-W5). On average, the follow-up waves
were carried out 5.2 (SD 3.2) years after the baseline
waves (see Table S1 in supplementary materials for pain
variable distribution and follow-up duration in the dif-
ferent studies).
Variables of interest
The outcome variable was the absence/presence of the
harmonized pain variable (defined as “self-reported pain
experienced at the time of the interview”) at follow-up.
Absence of pain was defined as absence of pain at both
baseline and follow-up wave, while presence of pain was
identified as absence of pain at baseline but presence of
pain at follow-up. In total, 91,278 subjects did not report
pain at baseline and, of them, 50,849 had complete data
on pain at follow-up: of them 36,023 still did not report
pain, whereas 14,826 (29.2%) reported pain.
Candidate predictors of pain were selected from the dif-
ferent domains defined in the ATHLOS harmonization.
Domain “Lifestyle and health behaviours”: current smok-
ing status, current alcohol use and engagement in vigor-
ous exercise; “Health status and functional limitations”:
level of energy, sleep quality, mobility walk, self-reported
health, presence of recent falls and evaluative wellbeing;
“Diseases”: diabetes, respiratory disease, hypertension,
joint disorders, angina, stroke, cancer and multimorbidity;
“Physical measures”: obesity; “Cognition, personality and
other psychological measures”: depression; “Social envir-
onment”: bereavement, i.e. the experience of a loss of any
close person. Moreover, in the domain “Socio-demo-
graphic and economic characteristics”, gender, marital sta-
tus, education, retirement status and wealth quintile of
participants were retrieved. All these variables were se-
lected from both baseline and follow-up waves (see Table
S2 in supplementary materials for the definition of harmo-
nized variables).
Data analysis
Initially, as a screening criterion, we excluded variables
with a relevant amount of missing that would have
dramatically reduced the sample size exploitable for the
present analysis. Second, predictors of pain were
assessed using univariable logistic regression models and
those with a p-value< 0.10 were retained in the subse-
quent analyses (see Table S2 in supplementary
materials).
Next, two stepwise forward logistic regressions were
performed (the p-value for variable inclusion and re-
moval were set to p < 0.05 and p < 0.15, respectively).
The first stepwise was performed with baseline variables
only as predictors of pain development at follow-up, and
later a multivariable logistic regression was implemented
retaining only statistically significant predictors (p <
0.05). Then, in the second stepwise, the significant pre-
dictors identified at baseline were kept in the model and
follow-up variables were included for selection. Lastly, a
final model was pursued with only significant predictors
at both baseline and follow-up. All models were
weighted and adjusted for a time-lag variable (defined as
the difference between the year of interview at follow-up
and baseline). Multicollinearity was checked using toler-
ance and Variance Inflation Factor (VIF): variables with
tolerance < 0.4 (VIF > 2.5) were discarded from the ana-
lysis. Engagement in vigorous exercise at follow-up was
discarded form the analyses due to collinearity. Models’
goodness-of-fit were assessed by the Hosmer and Leme-
show’s test and by visual inspection of the plot of esti-
mated values against residuals, whilst specification error
was evaluated by running a new regression with the
observed values against predicted and predicted-squared
values as independent variables. The Area Under the Re-
ceiver Operating Curve (AUC) and its 95% confidence
interval (95% CI) for the predicted versus the actual data
was also calculated. Categorical variables were reported
as proportions, and continuous variables were reported
as means ± standard deviations (SD) and medians with
interquartile ranges (IQRs). Odds ratios (ORs) were pre-
sented with their 95% CI and Z with its associated p-
value. All statistical analyses were performed using
STATA SE, version 15.0 (Stata Statistical Software: Re-
lease 12. College Station, TX: StataCorp LP).
Results
Almost all variables, at both baseline and follow-up,
were significant predictors of pain in univariable regres-
sion models (see Table S2 in supplementary materials):
the exceptions to this were being single (vs. married) at
baseline and being retired (vs. employed or student) at
follow-up.
Stepwise regression with baseline variables enabled
retaining eight predictors (gender, sleep problems,
engagement in vigorous exercise, bereavement, obesity,
self-rated health, multimorbidity and smoking), and
follow-up variables enabled retaining seven predictors
(energy level, difficulties with walking, respiratory
diseases, joint disorders, stroke and again self-rated
health and sleep problems). The full results of multivari-
able regression models are in supplementary materials
(see Table S3). The final sample size was composed of
13,545 subjects, 8197 without pain and 5348 that
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developed pain between baseline and follow-up, corre-
sponding to 39.5% of the sample.
Table 1 provides full features of the final sample. Fe-
males represented 53.3% of the entire sample, and aver-
age age moved from a median of 63 to a median of 68
years, and more than one-third of the sample was re-
tired. Most descriptive variables were almost similar at
the two time points, with some exceptions: for example,
difficulty walking increased from 9.7% to 18.7%, and
poor self-reported health from 5.1% to 8.9%. Among
health conditions, hypertension and joint disorders were
the two most common at baseline (37.4% and 26.6%, re-
spectively) and underwent a significant increase (51.6%
and 38.6% at follow-up, respectively), and multimorbid-
ity was experienced by 27.3% of participants at baseline
and 40.1% at follow-up. The same data are reported
study by study in supplementary materials (see Tables
S4, S5, S6, S7, S8, S9).
Table 2 reports the results of the following models:
Model 1, stepwise-selected baseline predictors; Model 2,
significant baseline predictors only (p < 0.05); Model 3,
significant baseline predictors and stepwise-selected
follow-up predictors. All baseline variables, with the ex-
clusion of smoking status and multimorbidity, were sig-
nificant risk factors for pain at 5.2 years’ follow-up. Once
variables selected at follow-up were included, baseline
self-rated health was no more significant, whereas the
corresponding follow-up variable was. Among newly in-
cluded variables, low-level energy/fatigue, difficulties
with walking, sleep problems and respiratory disease
were significant risk factors for pain occurrence, whereas
neither joint disorders nor stroke were significant
predictors.
Table 3 shows the results of the final model, where
significant predictors only were retained. Being female,
engaging in vigorous exercise, being obese and bereave-
ment were all risk factors for the onset of pain over an
average period of 5.2 years. In addition to this, low en-
ergy levels, difficulties with walking, non-good self-rated
health and presence of sleep problems were significant
risk factors for the presence of pain at the follow up.
Discussion
The results of this study, based on a large sample of gen-
eral ageing population, showed that 39.5% of respon-
dents developed pain over a five-year follow-up period
and that there are proximal and distal risk factors for
pain. Proximal risk factors include low energy level (or
fatigue), walking difficulties, self-rated health perceived
as not good and sleep problems, whereas distal risk fac-
tors – which predicted pain onset over a five-year time-
frame – included female gender, engaging in vigorous
exercise, being obese and suffering from the loss of a
close person. It is interesting to notice that two risk
factors, namely sleep problems and poorer self-rated
health were retained among distal ones, but they were
discarded from the final model once proximal risk fac-
tors were included.
What makes our results of such an importance is that
most of the risk factors herein included are modifiable,
either directly or indirectly. Factors that may be directly
addressed include sleep problems, obesity, engagement
in vigorous activities, low energy/fatigue and walking dif-
ficulties, whereas factors such as self-rated health can be
targeted through general health improvement interven-
tions, as well as through interventions aimed to address
some of the aforementioned targets, such as sleep im-
provement and weight loss. In addition to this, we did
not include age as a variable in our analysis, but decided
to include the ageing process itself, by weighting and
adjusting all our models for a time-lag variable, i.e. the
years passing between the two time points in each study.
Sleep problems may impact on pain in different ways,
and are part of common associated symptomatology in
different pain-related conditions affecting adults and
older adults, such as low back pain, headache disorders
or osteoarthritis [47–49]. As reported in a recent review
[50] several hypotheses have been made. Disrupted sleep
continuity (i.e. wakefulness during the night) may con-
tribute to increased pain perception (and higher opioids
consumption) through disruption of opioid circuits in-
volved in the descending pain modulatory systems, and
involvement of inflammatory mechanisms typical of
ageing-related conditions such as cardiovascular disor-
ders, hypertension and diabetes, has also been addressed.
In fact, sleep disturbance were associated with increases
in markers of systemic inflammation, such as
interleukin-6, which is known to sensitize nociceptors
and increase pain sensitivity [51]. It has to be acknowl-
edged that insomnia and reduced sleep hours are part of
the ageing process itself, with older people having diffi-
culty falling and staying asleep due to frequent arousals
[52]. Treatments are both pharmacological and non-
pharmacological [53–55]: among the first, benzodiaze-
pines, sedating low-dose antidepressants, antipsychotics
and anticonvulsants are included, whereas non-
pharmacological treatments mostly include cognitive be-
havioural therapy. There is a growing interest on behav-
ioural treatment for sleep disturbances in older adults
and elderlies, mostly in reason of their reduced risks and
hazards of sedative-hypnotics and opioids for middle-
aged and older adults, as well as in consideration of the
interaction between drugs prescribed for sleep problems
and those for other medical conditions [51, 53].
Obesity is another known factor contributing to pain,
through both inflammatory and mechanical processes
[56, 57]. Obesity is in fact a pro-inflammatory condition
and literature exists on the role of proinflammatory
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Table 1 Final regression model sample description
Baseline Follow-up
No pain at
follow-up
(N = 8197)
Pain at
follow-up
(N = 5348)
Total
(N = 13,545)
No pain at
follow-up
(N = 8197)
Pain at follow-up
(N = 5348)
Total
(N = 13,545)
Age, mean ± sd
[median: interquartile range]
59.8 ± 14.4
[64: 52–71]
60.62 ± 13.0
[62: 53–70]
60.1 ± 13.9
[63: 53–70]
65.5 ± 13.9
[70: 59–75]
64.9 ± 12.6
[66: 57–74]
65.3 ± 13.5
[68: 57–75]
Sex (N = 13,545) (N = 13,545)
Male 49.8% 41.9% 46.7% 49.8% 41.9% 46.7%
Female 50.2% 58.1% 53.3% 50.2% 58.1% 53.3%
Marital status (N = 13,529) (N = 13,526)
Married/cohabiting 71.1% 71.4% 71.2% 67.2% 67.2% 67.2%
Single 8.3% 8.0% 8.2% 7.5% 7.8% 7.6%
Divorced/Separated 7.1% 7.1% 7.1% 7.7% 7.3% 7.6%
Widow 13.5% 13.5% 13.5% 17.6% 17.7% 17.6%
Education (N = 11,384) (N = 9931)
Primary or less 28.6% 38.3% 32.5% 20.3% 31.6% 24.9%
Secondary or above 71.4% 61.7% 67.5% 79.7% 68.4% 75.1%
Retired (N = 12,984) (N = 12,974)
31.2% 34.3% 32.5% 41.9% 40.5% 41.3%
Household wealth quintile (N = 13,140) (N = 10,175)
1 - Lower 15.7% 20.0% 17.4 19.5% 23.3% 21.0%
2 17.6% 19.0% 18.2 18.4% 21.7% 19.7%
3 19.7% 17.9% 19.0 20.1% 19.7% 19.9%
4 23.5% 22.3% 23.0 21.1% 17.5% 19.7%
5 - Higher 23.5% 20.8% 22.4 20.9% 17.8% 19.7%
Smoking status, (N = 12,674) (N = 10,629)
Never 47.4% 51.4% 48.9% 44.0% 44.2% 44.0%
Former smoker 31.7% 25.1% 29.3% 39.8% 30.1% 36.9%
Current 20.9% 23.5% 21.8% 16.2% 25.7% 19.1%
Current alcohol consumption (N = 13,541) (N = 13,008)
57.2% 56.8% 57.1% 55.5% 56.0% 55.7%
Engaged in vigorous exercise (N = 13,545) (N = 11,901)
25.6% 38.7% 30.7% 21.4% 33.7% 26.3%
Low level of energy/Fatigue (N = 13,413) (N = 13,545)
25.7% 34.0% 28.9% 21.6% 43.8% 30.3%
Sleep problems (N = 13,430) (N = 13,545)
24.8% 35.9% 29.1% 25.8% 45.1% 33.3%
Difficulty walking by yourself (N = 12,972) (N = 13,545)
8.4% 11.6% 9.7% 14.1% 25.9% 18.7%
Self-reported health (N = 12,818) (N = 13,545)
Poor 3.5% 7.5% 5.1% 4.8% 15.1% 8.9%
Average/Fair/Moderate 19.6% 27.2% 22.6% 21.7% 34.6% 26.7%
Good 76.9% 65.3% 72.3% 73.5% 50.3% 64.4%
Recent falls (N = 9656) (N = 10,092)
26.2% 64.6% 42.4% 30.7% 68.2% 46.3%
Evaluative wellbeing, (N = 7178) (N = 9467)
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cytokines in producing a hyperalgesic state. Excess of
adipose tissue may in fact lead to an increased inflam-
matory response with through different chemical media-
tors involved in inflammation. Parallel to this, obesity
determines increased risk and severity of musculoskel-
etal conditions, such as back pain [58]. In fact, the over-
load over low back, hip and knee joints cause injury and
degradation to the cartilage and bone matrix in these
structures, leading to osteoarthritis. In addition to this,
known comorbidities of obesity that might exacerbate
pain have to be taken into account, in particular sleep
disorders (e.g. obstructive sleep apnoea) and depression
[57, 59–61]. Evidence exist that weight loss programs,
which include diet therapy and physical activity or, in
specific cases, bariatric surgery, have positive effect on
pain reduction in patients with different types of chronic
musculoskeletal pain [62], osteoarthritis [63], back and
knee pain [64], and migraine [65], and it showed to
reduce up to 50% the risk of developing osteoarthritis on
a 10-year period [66].
Exercising is protective for health in general, as also
stated in the recent consensus statement on physical ac-
tivity and ageing [67] where, however, an explicit men-
tion to the fact that benefits for health among older
adults can be realised at lower volumes and intensity
than with the usually recommended “150min of moder-
ate to vigorous intensity physical activity per week” is
made. Besides exposing people to a higher risk of sport-
related injuries, moderate to vigorous exercise is predict-
ive of the onset of back pain among ageing populations
[58, 68], worsening of osteoarthritis-related pain severity
[69]. Therefore, older adults and aging population
should engage in mild to moderate, rather than vigorous,
exercise.
Pain and fatigue have been found to be connected in
several conditions, in particular musculoskeletal
Table 1 Final regression model sample description (Continued)
Baseline Follow-up
No pain at
follow-up
(N = 8197)
Pain at
follow-up
(N = 5348)
Total
(N = 13,545)
No pain at
follow-up
(N = 8197)
Pain at follow-up
(N = 5348)
Total
(N = 13,545)
Low 5.7% 22.2% 14.4% 6.3% 25.0% 15.2%
Middle 20.8% 27.9% 24.5% 18.6% 28.2% 23.2%
High 73.5% 49.9% 61.1% 75.1% 46.8% 61.6%
Diabetes (N = 11,928) (N = 12,214)
11.8% 15.7% 13.1% 19.0% 19.6% 19.2%
Respiratory diseases (N = 13,531) (N = 12,084)
8.0% 9.2% 8.5% 10.7% 14.0% 12.0%
Hypertension (N = 13,527) (N = 12,609)
37.5% 37.4% 37.4% 50.8% 52.8% 51.6%
Joint disorders (N = 13,537) (N = 12,688)
26.6% 26.7% 26.6% 347% 44.4% 38.6%
Angina (N = 3453) (N = 3453)
1.5% 2.2% 1.7% 2.8% 4.5% 3.4%
Stroke (N = 13,535) (N = 12,084)
1.1% 1.9% 1.4% 1.7% 2.7% 2.1%
Cancer (N = 11,922) (N = 11,503)
1.7% 3.2% 2.3% 2.3% 4.6% 3.2%
Multimorbidity (N = 13,544) (N = 13,096)
27.6% 27.0% 27.3% 38.4% 42.6% 40.1%
Obesity (N = 13,545) (N = 11,245)
19.0% 23.1% 20.6% 21.2% 24.5% 22.5%
Depression (N = 13,302) (N = 13,451)
10.6% 22.3% 15.2% 10.6% 29.8% 18.1%
Experience of a loss of any close person (bereavement) (N = 13,545) (N = 13,536)
28.6% 44.5% 34.8% 33.4% 58.3% 43.1%
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Table 2 Hierarchical pain predictive models: stepwise-selected baseline predictors, significant baseline predictors only (p < 0.05),
significant baseline predictors and stepwise-selected follow-up predictors
Model 1: stepwise-selected
baseline predictors
(N = 16,097)
Model 2: baseline with
significant predictors only
(N = 16,979)
Model 3: significant baseline
predictors and stepwise-
selected follow-up predictors
(N = 11,852)
OR (95% CI) Z (p-value) OR (95% CI) Z (p-value) OR (95% CI) Z (p-value)
Baseline Variables
Female gender 1.39 (1.24–1.56) 5.51 (<.001) 1.42 (1.28–1.58) 6.49 (<.001) 1.36 (1.18–1.56) 4.34 (<.001)
Engage in vigorous exercise 1.50 (1.32–1.71) 6.10 (<.001) 1.73 (1.53–1.95) 8.93 (<.001) 3.10 (2.64–3.64) 13.69 (<.001)
Bereavement 1.31 (1.17–1.46) 4.59 (<.001) 1.50 (1.35–1.67) 7.44 (<.001) 1.90 (1.64–2.20) 8.52 (<.001)
Obesity 1.23 (1.09–1.38) 3.45 (.001) 1.22 (1.09–1.36) 3.37 (<.001) 1.17 (1.00–1.36) 1.97 (.049)
Self-rated health – average to moderate (vs. good) 1.65 (1.44–1.89) 7.23 (<.001) 1.75 (1.54–1.99) 8.64 (<.001) 1.07 (0.89–1.28) 0.68 (.499)
Self-rated health – poor (vs. good) 2.24 (1.78–2.81) 6.97 (<.001) 2.26 (1.82–2.81) 7.35 (<.001) 0.95 (0.61–1.48) −0.23 (.819)
Sleep problems 1.35 (1.21–1.52) 5.13 (<.001) 1.41 (1.26–1.57) 5.98 (<.001) 1.25 (1.07–1.46) 2.78 (.005)
Multimorbidity 1.10 (0.98–1.24) 1.60 (.109) – – – –
Smoking – Former smoker (vs. never smoker) 0.87 (0.77–1.00) −2.02 (.043) – – – –
Smoking – Current smoker (vs. never smoker) 1.15 (0.98–1.24) 1.91 (.056) – – – –
Follow-up Variables
Low energy level/Fatigue 1.97 (1.67–2.32) 8.15 (<.001)
Self-rated health – average to moderate (vs. good) 2.32 (1.94–2.78 9.19 (<.001)
Self-rated health – poor (vs. good) 3.80 (2.57–5.60) 6.71 (<.001)
Difficulties with walking 1.52 (1.26–1.83) 4.35 (<.001)
Sleep problems 1.88 (1.61–2.18) 8.13 (<.001)
Respiratory disease 1.26 (1.03–1.56) 2.19 (.028)
Joint disorders 0.96 (0.83–1.11) −0.57 (.571)
Stroke 0.90 (0.54–1.52) −0.38 (.702)
Notes. Model 1: Hosmer-Lemeshow’s p-value = .085; AUC 0.64 (95% CI: 0.63–0.65). Model 2: Hosmer-Lemeshow’s p-value = .038; AUC 0.65 (95% CI: 0.64–0.66).
Model 3: Hosmer-Lemeshow’s p-value = .010; AUC 0.79 (95% CI: 0.78–0.80)
Table 3 Final hierarchical pain predictive model
Model 4: significant baseline and follow-up predictors
(N = 13,545)
OR (95%CI) Z (p-value)
Baseline Variables
Female gender 1.34 (1.18–1.51) 4.61 (<.001)
Engage in vigorous exercise 2.51 (2.18–2.89) 12.71 (<.001)
Bereavement 1.88 (1.65–2.15) 9.39 (<.001)
Obesity 1.36 (1.18–1.57) 4.20 (<.001)
Follow-up Variables
Low energy level/Fatigue 1.93 (1.68–2.20) 9.27 (<.001)
Self-rated health – average to moderate (vs. good) 1.57 (1.36–1.82) 6.04 (<.001)
Self-rated health – poor (vs. good) 2.20 (1.71–2.83) 6.13 (<.001)
Difficulties with walking 1.69 (1.43–1.99) 6.12 (<.001)
Sleep problems 1.80 (1.58–2.05) 8.97 (<.001)
Note: Hosmer-Lemeshow’s p-value = .001; AUC 0.77 (95% CI 0.76–0.78)
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disorders such as rheumatoid arthritis and neuromuscu-
lar disorders such as fibromyalgia and chronic fatigue
syndrome, and it is besides associated to poor sleep and
symptoms of anxiety and depression [70–73]. However,
the way in which fatigue exerts its effect on pain is un-
clear, but some hypotheses have been postulated, which
include a common pathway mediated by inflammatory
processes, such as increased levels of pro-inflammatory
cytokines, and sensitisation of muscle nociceptors [72,
74]. Treatment strategy for fatigue include nutraceuti-
cals, although with conflicting results [75–77], and exer-
cise therapy [78].
Walking difficulties can be the outcome of several
health problems – such as stroke, obesity or osteoarth-
ritis – and thus require disease-specific treatments. For
example, in post-stroke patients gait difficulties are very
common and generally due to impairments in muscle
strength, muscle tone, control over voluntary movement
and balance, which result in reduced walking speed,
temporal and spatial inter-limb asymmetries or impaired
balance control [79]. Therefore, approaches to gait and
walking rehabilitation in stroke survivors will need to
address different impairments, making it really a patient-
specific treatment. Among obese subjects, walking im-
pairments are often due to knee osteoarthritis [80] and
respiratory impairment or comorbidities [81, 82], and re-
habilitation programmes for obesity reduction include
moderate exercise aimed to improve walking, with posi-
tive effect on pain outcomes [62–64].
Conversely, our final model did not include some
risk factors that have been found in previous litera-
ture, including sociodemographic data such as educa-
tion and unemployment [35, 36], risk factors such as
smoking [44], and health condition such as depres-
sion, diabetes, stroke, musculoskeletal diseases and
multimorbidity status [6, 26, 28–30, 32, 34, 35, 39–
41]. Some of them, namely smoking status vs. never
smoking, multimorbidity, joint disorders or stroke,
were included in the model, but not retained when
other variables were included or when the final model
with significant predictors only was run. The reason
for this lack of predictive power is likely due to the
large amount of variable we used, most of which were
significantly associated in univariable analyses (see
Table S2 in supplementary materials). A separate note
has to be made for depression which was not selected
from the stepwise logistic regression. Our data
showed in fact that bereavement, i.e. the loss of a
close person, was predictive of pain over a five-year
period, whereas depression was not. Some studies
showed that in some bereaved individuals the death
of a loved one precipitates a combination of symp-
toms of both grief and depression, as well as of trau-
matic stress, although the categories are not
overlapping [83–85], and depression was found in
18% to 55% of bereaved people [86–88]. Our hypoth-
esis is that in a sample of ageing population like the
one we analysed – where one-third of participants at
baseline reported the experience of the loss of a close
person, and 15% reported depression – the experience
of bereavement confounded and overcame the pre-
dictive power of depression towards pain prediction.
In addition to this, have no indication on the amount
of time that passed between the loss experience and
the interview, and on the presence of a problematic
grief among bereaved people in our sample.
Some limitations have to be acknowledged. First,
the variables used for our analysis are from a harmo-
nized dataset, with a clear simplification from their
original formulation. The main outcome definition is
“self-reported pain experienced at the time of the
interview”, with a dichotomous output, and, for most
of the studies herein used, the original items ad-
dressed pain in terms of severity and impact of pain,
which spans between mild and disabling. Another
variable for which relevant differences exist is “energy
level” which in some studies (e.g. COURAGE in Eur-
ope) was addressed in terms of the amount of energy
the person had (with response options varying be-
tween “not at all” and “completely”) [89], whereas
other studies (e.g. CHARLS) addressed it in terms of
fatigue or “feeling that everything is an effort” (with
response options based on frequency, from “rarely” to
“most or all of the time”) [90]. Second, there is a
considerable variation in the lag between waves across
studies, which varied between 2 and 11 years: we in-
cluded the lag variable so to interpret predictors con-
trolling for the difference between respondents’ ageing
across studies. Third, stepwise regression, which had
the merit to enable reducing the amount of predictors
to significant ones, present intrinsic problems, in par-
ticular biased high R2 values, small standard error
and narrow 95% CI for odd ratios, small and difficult
to correct p-values due to multiple comparisons and
exacerbated collinearity problems [91]. Fourth, when
we selected the variables to be included in the
models, we had to face the problems of variable miss-
ing values, which prevented some of them from being
included (e.g. the variables “History of angina” and
“Myocardial infarction or heart attack” had 51% and
55% of missing, respectively, whereas “recent falls”
which his intuitively of importance had 47% of miss-
ing). Possible solutions preserving to loose sample
would have included treating them as a separate cat-
egory by itself and data imputation. The problem with
the first is that it would have led to biased estimation
in regression coefficients. Imputation of missing
values, e.g. through mean imputation or regression-
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based imputation, was not considered in reason of
the very limited set of records, namely around 2000
out of the 50,849 not referring pain at baseline and
with complete pain information at follow-up, with
complete information for the remaining variables of
interest: the reliability of a model with such a large
amount of imputed values would have been at least
debatable.
Conclusions
In conclusion, we showed that over a five-year period
39.5% of respondents from this ageing population that
did not experience pain at baseline, developed pain at
follow-up, and that there are distal and proximal risk
factors for new pain onset. The first group included fe-
male gender, engaging in vigorous activities, being obese
and suffering from the loss of a close person, whereas
the second included low energy level (or fatigue), walk-
ing difficulties, self-rated health perceived as not good
and sleep problems. Part of these predictors are directly
modifiable: therefore, it is expectable that actions aimed
at improving sleep, reducing weight among obese people
and treating fatigue would positively impact on pain on-
set. In addition, indication to avoid vigorous exercise
should also be provided to people aged around 60 years
or older, in particular if female or obese.
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